September 07, 2015
1 min read
Save

Diabetic retinopathy rare in children with diabetes mellitus

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Researchers recommended that examinations for diabetic retinopathy could largely begin at 15 years old or later, in a study recently published in Ophthalmology.

Geloneck and colleagues explained that this is due to the prevalence of diabetic retinopathy (DR) that they determined in their retrospective, consecutive cohort study.

The study included 370 children with diabetes mellitus (DM) who were younger than 18 years. In reviewing their data, researchers noted the children’s eye examination results, which included cycloplegic refraction and dilated funduscopy, and noted durations of diabetes before a diagnosis of diabetic retinopathy as well as the youngest reported age of diabetic retinopathy.

Results showed that the children had a mean duration of diabetes mellitus of 5.2 years, and no children had diabetic retinopathy. Researchers identified the shortest disease duration as 5 years and the youngest age of patient diagnosed with severe diabetic retinopathy as 15 years old.

"Vision-threatening DR is extremely rare in children, regardless of the duration or control of DM," the researchers wrote. "Current screening guidelines seem to create an unnecessary financial and logistic burden for families and unnecessary appropriation of resources of pediatric ophthalmologists and the health care system."

They continued: "On the basis of the available evidence, we believe that screening examinations for DR could begin at age 15 years or after 5 years of DM duration, whichever occurs later, with an exception made for high-risk children and type 2 diabetic children. Annual examinations could then continue into adulthood, when the risk of developing sight-threatening DR increases."

Researchers also suggested that a group edit current DR screening guidelines. – by Chelsea Frajerman Pardes

Disclosure: The authors reported no relevant financial disclosures.